Hotgen(SH:688068) Zheng Quan Ri Bao Zhi Sheng·2026-01-16 15:17Core Viewpoint - The company emphasizes its commitment to expanding its overseas market presence and promoting its products in the in vitro diagnostic field, with significant achievements in obtaining international medical device registrations and certifications [1] Group 1: International Market Expansion - As of the first half of 2025, the company has obtained 604 international medical device registrations/product filings, including 261 CE certifications in the EU [1] - The company's products are now available in dozens of countries and regions, including Europe, Southeast Asia, South Asia, the Middle East, Africa, and the Americas [1] - The company has established offices in Southeast Asia and subsidiaries in India and the United States to enhance its international market reach [1] Group 2: Product and Sales Strategy - The company plans to respond actively to domestic and international market demands by diversifying its product offerings [1] - It aims to participate in various promotional activities and strengthen collaborations with major overseas clients to expand its sales channels [1] - The company is focused on improving its international market development capabilities and enhancing its core competitiveness [1]